Issue 11, 2002

Relocalization of cationic porphyrins during photodynamic therapy

Abstract

When photodynamic therapy is directed against sub-cellular sites that include mitochondria, the anti-apoptotic protein Bcl-2, lysosomes or the endoplasmic reticulum, there is generally an apoptotic response leading to cell death. We previously reported that the targeting of the plasma membrane by photosensitizing agents led to either a marked delay or inhibition of apoptosis, even if other sub-cellular sites were also targeted for photodamage. Preliminary studies indicated that this result was associated with photodamage to caspase-3, a major element of the ‘execution’ phase of apoptosis. We describe here a mechanism for apoptosis inhibition resulting from localization of photosensitizers from the membrane to the cytosol during irradiation, leading to selective photodamage of procaspases-9, and -3.

Graphical abstract: Relocalization of cationic porphyrins during photodynamic therapy

Article information

Article type
Paper
Submitted
24 Jun 2002
Accepted
24 Sep 2002
First published
07 Oct 2002

Photochem. Photobiol. Sci., 2002,1, 837-840

Relocalization of cationic porphyrins during photodynamic therapy

D. Kessel, Photochem. Photobiol. Sci., 2002, 1, 837 DOI: 10.1039/B206046A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements